4
Changes in Ownership
Indaptus Therapeutics, Inc. Filed Acc 0001641172-25-003826
Options or other derivatives
- Chief Financial Officer returned 7,041 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Sassi Nir · Chief Financial Officer
Table II: Derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-04-10 | Returned to the company : show line 1 in the form Stock Option (right to buy) | −1,250 | $0.07 | $89 | 0 | D |
| 2025-04-10 | Returned to the company : show line 2 in the form Stock Option (right to buy) | −1,125 | $0.07 | $80 | 0 | D |
| 2025-04-10 | Returned to the company : show line 3 in the form Stock Option (right to buy) | −2,500 | $0.07 | $178 | 0 | D |
| 2025-04-10 | Returned to the company : show line 4 in the form Stock Option (right to buy) | −500 | $0.07 | $36 | 0 | D |
| 2025-04-10 | Returned to the company : show line 5 in the form Stock Option (right to buy) | −500 | $0.07 | $36 | 0 | D |
| 2025-04-10 | Returned to the company : show line 6 in the form Stock Option (right to buy) | −41 | $0.07 | $3 | 0 | D |
| 2025-04-10 | Returned to the company : show line 7 in the form Stock Option (right to buy) | −1,125 | $0.07 | $80 | 0 | D |
Loading xslF345X05/ownership.xml…